<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study the mechanisms of the regulation of the tyrosine phosphorylation of <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor subunit 2B(NR2B) in the gerbil hippocampal synaptosomes following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion (I/R) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Transient (15 min) <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was produced by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> procedure </plain></SENT>
<SENT sid="2" pm="."><plain>The tyrosine phosphorylation of NR2B was analyzed by immunoprecipitation and immunoblot assay </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 15 min caused a marked decrease in the levels of tyrosine phosphorylation of many protein bands including 180 kDa protein </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">Transient ischemia</z:e> followed by reperfusion induced rapid (within 15 min of reperfusion), and sustained (for at least 48 h) increase in the tyrosine phosphorylation of many protein bands including 180 kDa protein </plain></SENT>
<SENT sid="5" pm="."><plain>Immunoprecipitation and immunoblot confirmed that NR2B is among the phosphorylated 180 kDa protein </plain></SENT>
<SENT sid="6" pm="."><plain>Maximal phosphorylation of 180 kDa band corresponding to NR2B (1.8 fold relative to sham-operated controls) was reached at 6 h of reperfusion following 15 min of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>But the level of protein expression of NR2B did not change </plain></SENT>
<SENT sid="8" pm="."><plain>Administration of ketamine (KT), a non-competitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, or <z:chebi fb="1" ids="7565">nifedipine</z:chebi> (ND), an L-type voltage gated calcium channel (L-type VGCC) blocker, 20 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> attenuated stimulation of the tyrosine phosphorylation of NR2B without affecting the level of protein expression of NR2B </plain></SENT>
<SENT sid="9" pm="."><plain>Under these conditions, non-<z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> 6,7-dinitroquinoxaline-2,3-dione (DNQX) had no effect on the level of tyrosine phosphorylation </plain></SENT>
<SENT sid="10" pm="."><plain>Protein tyrosine phosphatase (<z:chebi fb="0" ids="52242">PTP</z:chebi>) inhibitor vanadate and protein tyrosine kinase (PTK) inhibitor genestein resulted in the increase and the decrease of the tyrosine phosphorylation of NR2B, respectively </plain></SENT>
<SENT sid="11" pm="."><plain>Src coprecipitated with NR2B protein </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: The increase of the tyrosine phosphorylation of NR2B induced by I/R has relation to NR and L-type VGCC; PTK and <z:chebi fb="0" ids="52242">PTP</z:chebi> participate in the regulation of the tyrosine phosphorylation of NR2B during I/R </plain></SENT>
<SENT sid="13" pm="."><plain>Src that associates with NR2B may play an important role in the regulation of the tyrosine phosphorylation of NR2B during I/R </plain></SENT>
</text></document>